The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for East Bridge Capital Master Fund I Ltd
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Foreign investor East Bridge Capital Master Fund I Ltd sold 128,235 shares (0.08%) of Jubilant Pharmova on 30 May 2025 through a market transaction. Its holding in the company declined from 3.51% (55,96,522 shares) to 3.43% (54,68,287 shares). The acquirer confirmed it does not belong to the promoter or promoter group. No encumbrance, warrants or convertible instruments were involved in the transaction. The filing is a routine SEBI disclosure triggered because the shareholding change crossed the reporting threshold.
This is a small, routine open-market sale by a foreign institutional investor, reducing its stake marginally by 0.08%. It is unlikely to have any meaningful impact on the stock price or long-term investor sentiment, as the fund remains a sizeable shareholder with over 3% holding.